In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Division of Caladrius Biosciences Inc.

Latest From NeoStem

Deals Shaping The Medical Industry, January 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014.

BioPharmaceutical Medical Device

Suzhou Erye Of China To Lose 51% Stakeholder NeoStem Of U.S.

China's Suzhou Erye Pharmaceutical generics maker is losing its majority stakeholder, as U.S.-based NeoStem offers its 51% stake for sale for $12.3 million.

See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Caladrius Biosciences Inc.
  • Senior Management
  • Denis Rodgerson, PhD, Pres. & CEO
    Larry May, CFO
    Simon Lam, VP, Bus. Dev.
    Brad Maroni, MD, VP, Clinical Dev.
    Edward Garnett, VP, Sales & Mktg.
  • Contact Info
  • NeoStem
    Phone: (818) 991-8770
    28720 Canwood St.
    Ste. 208
    Agoura Hills, CA 91301